These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 35874727)

  • 1. Transcriptome Analysis of Tumor-Infiltrating Lymphocytes Identifies NK Cell Gene Signatures Associated With Lymphocyte Infiltration and Survival in Soft Tissue Sarcomas.
    Judge SJ; Bloomstein JD; Sholevar CJ; Darrow MA; Stoffel KM; Vick LV; Dunai C; Cruz SM; Razmara AM; Monjazeb AM; Rebhun RB; Murphy WJ; Canter RJ
    Front Immunol; 2022; 13():893177. PubMed ID: 35874727
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of tumor-infiltrating NK and T cells highlights IL-15 stimulation and TIGIT blockade as a combination immunotherapy strategy for soft tissue sarcomas.
    Judge SJ; Darrow MA; Thorpe SW; Gingrich AA; O'Donnell EF; Bellini AR; Sturgill IR; Vick LV; Dunai C; Stoffel KM; Lyu Y; Chen S; Cho M; Rebhun RB; Monjazeb AM; Murphy WJ; Canter RJ
    J Immunother Cancer; 2020 Nov; 8(2):. PubMed ID: 33158916
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intratumoral NKp46
    Cruz SM; Sholevar CJ; Judge SJ; Darrow MA; Iranpur KR; Farley LE; Lammers M; Razmara AM; Dunai C; Gingrich AA; Persky J; Mori H; Thorpe SW; Monjazeb AM; Murphy WJ; Canter RJ
    Front Immunol; 2023; 14():1230534. PubMed ID: 37545516
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of Germline Variants in Natural Killer Cells With Tumor Immune Microenvironment Subtypes, Tumor-Infiltrating Lymphocytes, Immunotherapy Response, Clinical Outcomes, and Cancer Risk.
    Xu X; Li J; Zou J; Feng X; Zhang C; Zheng R; Duanmu W; Saha-Mandal A; Ming Z; Wang E
    JAMA Netw Open; 2019 Sep; 2(9):e199292. PubMed ID: 31483464
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Transcriptional Signature of PDGF-DD Activated Natural Killer Cells Predicts More Favorable Prognosis in Low-Grade Glioma.
    Sun Y; Sedgwick AJ; Palarasah Y; Mangiola S; Barrow AD
    Front Immunol; 2021; 12():668391. PubMed ID: 34539622
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Circulating and Tumor-Infiltrating NK Cells From Clear Cell Renal Cell Carcinoma Patients Exhibit a Predominantly Inhibitory Phenotype Characterized by Overexpression of CD85j, CD45, CD48 and PD-1.
    Ziblat A; Iraolagoitia XLR; Nuñez SY; Torres NI; Secchiari F; Sierra JM; Spallanzani RG; Rovegno A; Secin FP; Fuertes MB; Domaica CI; Zwirner NW
    Front Immunol; 2021; 12():681615. PubMed ID: 34149719
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Boosting Natural Killer Cell-Mediated Targeting of Sarcoma Through DNAM-1 and NKG2D.
    Sayitoglu EC; Georgoudaki AM; Chrobok M; Ozkazanc D; Josey BJ; Arif M; Kusser K; Hartman M; Chinn TM; Potens R; Pamukcu C; Krueger R; Zhang C; Mardinoglu A; Alici E; Temple HT; Sutlu T; Duru AD
    Front Immunol; 2020; 11():40. PubMed ID: 32082316
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The construction and analysis of tumor-infiltrating immune cell and ceRNA networks in recurrent soft tissue sarcoma.
    Huang R; Meng T; Chen R; Yan P; Zhang J; Hu P; Zhu X; Yin H; Song D; Huang Z
    Aging (Albany NY); 2019 Nov; 11(22):10116-10143. PubMed ID: 31739284
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Gene Signature Predicting Natural Killer Cell Infiltration and Improved Survival in Melanoma Patients.
    Cursons J; Souza-Fonseca-Guimaraes F; Foroutan M; Anderson A; Hollande F; Hediyeh-Zadeh S; Behren A; Huntington ND; Davis MJ
    Cancer Immunol Res; 2019 Jul; 7(7):1162-1174. PubMed ID: 31088844
    [TBL] [Abstract][Full Text] [Related]  

  • 10. T-cell infiltration and clonality correlate with programmed cell death protein 1 and programmed death-ligand 1 expression in patients with soft tissue sarcomas.
    Pollack SM; He Q; Yearley JH; Emerson R; Vignali M; Zhang Y; Redman MW; Baker KK; Cooper S; Donahue B; Loggers ET; Cranmer LD; Spraker MB; Seo YD; Pillarisetty VG; Ricciotti RW; Hoch BL; McClanahan TK; Murphy E; Blumenschein WM; Townson SM; Benzeno S; Riddell SR; Jones RL
    Cancer; 2017 Sep; 123(17):3291-3304. PubMed ID: 28463396
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Natural immune reactivity-associated therapeutic response in patients with metastatic renal cell carcinoma receiving tumor-infiltrating lymphocytes and interleukin-2-based therapy.
    Belldegrun A; Tso CL; Kaboo R; Pang S; Pierce W; deKernion JB; Figlin R
    J Immunother Emphasis Tumor Immunol; 1996 Mar; 19(2):149-61. PubMed ID: 8732698
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immune-cell infiltration in high-grade soft tissue sarcomas; prognostic implications of tumor-associated macrophages and B-cells.
    Nyström H; Jönsson M; Nilbert M; Carneiro A
    Acta Oncol; 2023 Jan; 62(1):33-39. PubMed ID: 36786033
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytotoxic markers and frequency predict functional capacity of natural killer cells infiltrating renal cell carcinoma.
    Schleypen JS; Baur N; Kammerer R; Nelson PJ; Rohrmann K; Gröne EF; Hohenfellner M; Haferkamp A; Pohla H; Schendel DJ; Falk CS; Noessner E
    Clin Cancer Res; 2006 Feb; 12(3 Pt 1):718-25. PubMed ID: 16467081
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Study of tumor-infiltrating lymphocytes for adoptive therapy of renal cell carcinoma (RCC) and metastatic melanoma: sequential proliferation of cytotoxic natural killer and noncytotoxic T cells in RCC.
    Hayakawa K; Salmeron MA; Parkinson DR; Markowitz AB; von Eschenbach AC; Legha SS; Balch CM; Ross MI; Augustus LB; Itoh K
    J Immunother (1991); 1991 Oct; 10(5):313-25. PubMed ID: 1790139
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic attributes of immune signatures in soft tissue sarcomas show differential dependencies on tumor mutational burden.
    Raj SKS; Routh ED; Chou JW; Votanopoulos KI; Triozzi PL; Miller LD
    Cancer; 2022 Sep; 128(17):3254-3264. PubMed ID: 35767280
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor infiltrating NK cell (TINK) subsets and functional molecules in patients with breast cancer.
    Rezaeifard S; Talei A; Shariat M; Erfani N
    Mol Immunol; 2021 Aug; 136():161-167. PubMed ID: 34171565
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Ratio of Exhausted to Resident Infiltrating Lymphocytes Is Prognostic for Colorectal Cancer Patient Outcome.
    Foroutan M; Molania R; Pfefferle A; Behrenbruch C; Scheer S; Kallies A; Speed TP; Cursons J; Huntington ND
    Cancer Immunol Res; 2021 Oct; 9(10):1125-1140. PubMed ID: 34413087
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical and immunological characteristics of sarcomas patients with clonogenic tumors.
    Avdonkina NA; Danilova AB; Nekhaeva TL; Prosekina EA; Emelyanova NV; Novik AV; Girdyuk DV; Gafton GI; Baldueva IA
    Immunobiology; 2021 Jul; 226(4):152094. PubMed ID: 34052775
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Colorectal Cancer-Associated Immune Exhaustion Involves T and B Lymphocytes and Conventional NK Cells and Correlates With a Shorter Overall Survival.
    Sorrentino C; D'Antonio L; Fieni C; Ciummo SL; Di Carlo E
    Front Immunol; 2021; 12():778329. PubMed ID: 34975867
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comprehensive analysis of immune infiltration in the tumor microenvironment of osteosarcoma.
    Yang H; Zhao L; Zhang Y; Li FF
    Cancer Med; 2021 Aug; 10(16):5696-5711. PubMed ID: 34258887
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.